|
|
| Dr. Jeffrey Popma and Dr. Raimund Erbel discuss the PROGRESS-AMS study |
Dr. Jeffrey Popma and Dr. Raimund Erbel discuss the PROGRESS-AMS study. The PROGRESS-AMS
study evaluates the benefits of a temporary bioadsorbable scaffolding mechanism inside the
coronary arteries (temporary stenting). The reasons for using magnesium as the stent
material are explained. The 12 month results of the trial are discussed (endpoints
discussed include: death, QWMI, TVR, late stent thrombosis). IVUS and angiography were
used to examine the results of stenting. Dr. Erbel outlines the safety issues associated
with the magnesium stent as it is absorbed. Dr. Erbel assesses what the future holds for
the bioadsorbable stent studied in the PROGRESS-AMS trial, specifically whether it should
be used as a BMS or DES.
[ Download video ] |
|
No comments have been submitted
|